Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 16.41% is in line with its 5-year average of 15.81%, near the high end of its 5-year range (-119.96%–37.57%).
7.12% below its 12-month average of 17.67%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 27.39%.
EBITDA MARGIN
16.41%
EBITDA MARGIN AVG TTM
17.67%
EBITDA MARGIN AVG 3Y
13.44%
EBITDA MARGIN AVG 5Y
15.81%
EBITDA MARGIN AVG 10Y
15.61%
EBITDA MARGIN AVG 15Y
17.67%
EBITDA MARGIN AVG 20Y
18.12%
CURRENT VS TTM AVG
-7.12%
CURRENT VS 3Y AVG
+22.07%
CURRENT VS 5Y AVG
+3.77%
CURRENT VS 10Y AVG
+5.11%
CURRENT VS 15Y AVG
-7.14%
CURRENT VS 20Y AVG
-9.42%
DENTSPLY SIRONA Inc.
Market Cap
$2.10B
EBITDA Margin
16.41%
TTM Avg
17.67%
3Y Avg
13.44%
5Y Avg
15.81%
Market Cap
$2.84B
EBITDA Margin
22.42%
TTM Avg
17.70%
3Y Avg
-0.76%
5Y Avg
-37.34%
Market Cap
$1.12B
EBITDA Margin
3.96%
TTM Avg
-13.21%
3Y Avg
-146.19%
5Y Avg
-104.68%
Market Cap
$384.28M
EBITDA Margin
-48.80%
TTM Avg
-44.09%
3Y Avg
-45.35%
5Y Avg
-45.35%
Market Cap
$16.49M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.16B
EBITDA Margin
21.06%
TTM Avg
20.50%
3Y Avg
18.63%
5Y Avg
16.67%
Market Cap
$6.14B
EBITDA Margin
6.82%
TTM Avg
6.08%
3Y Avg
-0.44%
5Y Avg
-8.67%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DENTSPLY SIRONA Inc. (XRAY) | $2.10B | 16.41% | 17.67% | 13.44% | 15.81% |
| TransMedics Group, Inc. (TMDX)vs › | $2.84B | 22.42% | 17.70% | -0.76% | -37.34% |
| Teladoc Health, Inc. (TDOC)vs › | $1.12B | 3.96% | -13.21% | -146.19% | -104.68% |
| NRC Health (NRC)vs › | $475.98M | 21.99% | 25.40% | 28.98% | 31.97% |
| Shoulder Innovations, Inc. (SI)vs › | $384.28M | -48.80% | -44.09% | -45.35% | -45.35% |
| PDS Biotechnology Corporation (PDSB)vs › | $16.49M | N/A | N/A | N/A | N/A |
| Doximity, Inc. (DOCS)vs › | $4.78B | 35.56% | 38.69% | 36.58% | 34.55% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.16B | 21.06% | 20.50% | 18.63% | 16.67% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.14B | 6.82% | 6.08% | -0.44% | -8.67% |
| Scholar Rock Holding Corporation (SRRK)vs › | $6.64B | -395.82% | -536.17% | -471.62% | -471.62% |
Gross Margin
49.5%
EBITDA Margin
16.4%
Operating Margin
11.7%
Net Margin
-15.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 27.39% |
| 2026-03-31 | 12.39% |
| 2025-12-31 | 37.57% |
| 2025-09-30 | 15.27% |
| 2025-06-30 | -4.27% |
| 2025-03-31 | 16.15% |
| 2024-12-31 | -46.52% |
| 2024-09-30 | -39.22% |
| 2024-06-30 | 13.82% |
| 2024-03-31 | 13.43% |
| 2023-12-31 | 15.61% |
| 2023-09-30 | -15.63% |
| 2023-06-30 | 16.15% |
| 2023-03-31 | 8.38% |
| 2022-12-31 | 14.65% |
| 2022-09-30 | -119.96% |
| 2022-06-30 | 19.75% |
| 2022-03-31 | 18.68% |
| 2021-12-31 | 21.97% |
| 2021-09-30 | 20.87% |
| 2021-06-30 | 22.79% |
| 2021-03-31 | 23.20% |
| 2020-12-31 | 20.60% |
| 2020-09-30 | 18.12% |
| 2020-06-30 | -4.89% |
| 2020-03-31 | -5.26% |
| 2019-12-31 | 19.33% |
| 2019-09-30 | 19.55% |
| 2019-06-30 | 14.89% |
| 2019-03-31 | 13.78% |
| 2018-12-31 | 15.05% |
| 2018-09-30 | 13.97% |
| 2018-06-30 | -102.52% |
| 2018-03-31 | 15.89% |
| 2017-12-31 | -59.34% |
| 2017-09-30 | 18.67% |
| 2017-06-30 | -97.73% |
| 2017-03-31 | 17.80% |
| 2016-12-31 | 20.97% |
| 2016-09-30 | 21.25% |
| 2016-06-30 | 19.24% |
| 2016-03-31 | 15.27% |
| 2015-12-31 | 18.12% |
| 2015-09-30 | 20.40% |
| 2015-06-30 | 16.65% |
| 2015-03-31 | 19.49% |
| 2014-12-31 | 18.49% |
| 2014-09-30 | 20.08% |
| 2014-06-30 | 20.91% |
| 2014-03-31 | 19.11% |
| 2013-12-31 | 17.13% |
| 2013-09-30 | 19.33% |
| 2013-06-30 | 20.46% |
| 2013-03-31 | 17.24% |
| 2012-12-31 | 17.21% |
| 2012-09-30 | 16.83% |
| 2012-06-30 | 18.57% |
| 2012-03-31 | 17.13% |
| 2011-12-31 | 11.72% |
| 2011-09-30 | 10.75% |
| 2011-06-30 | 19.12% |
| 2011-03-31 | 20.36% |
| 2010-12-31 | 19.67% |
| 2010-09-30 | 19.62% |
| 2010-06-30 | 21.48% |
| 2010-03-31 | 19.62% |
| 2009-12-31 | 20.96% |
| 2009-09-30 | 10.67% |
| 2009-06-30 | 10.82% |
| 2009-03-31 | 20.23% |
| 2008-12-31 | 19.45% |
| 2008-09-30 | 18.12% |
| 2008-06-30 | 21.39% |
| 2008-03-31 | 20.55% |
| 2007-12-31 | 20.33% |
| 2007-09-30 | 19.47% |
| 2007-06-30 | 20.87% |
| 2007-03-31 | 19.91% |
| 2006-12-31 | 19.41% |
| 2006-09-30 | 20.83% |
| 2006-06-30 | 20.72% |
| 2006-03-31 | 19.05% |
| 2005-12-31 | -2.39% |
| 2005-09-30 | -10.60% |
| 2005-06-30 | 21.30% |
| 2005-03-31 | 20.53% |
| 2004-12-31 | 19.89% |
| 2004-09-30 | 20.52% |
| 2004-06-30 | 20.95% |
| 2004-03-31 | 20.01% |
| 2003-12-31 | 21.98% |
| 2003-09-30 | 19.30% |
| 2003-06-30 | 20.08% |
| 2003-03-31 | 18.71% |
| 2002-12-31 | 19.79% |
| 2002-09-30 | 19.68% |
